Search Results - "Vida, MA Castro"

4CPS-158 Improvement in patient care by pharmacist phone call after starting treatment by Urda Romacho, J, Bretones Pedrinaci, I, Jofre Peralta, A, Castro Vida, MA

“…Background and ImportanceOutpatient Pharmacy Unit (OPU) is the last place that patient goes within the hospital circuit. Usually, patient arrives overloaded…”
Get full text

4CPS-090 Efficacy and safety of pangenotypic treatments in hepatitis C virus (HCV) patients by Urda, J, Herrera Expósito, M, Jofre Peralta, A, Castro Vida, MA

“…Background and importanceHepatitis C virus (HCV) is one of the leading causes of progressive liver damage, cirrhosis and hepatocellular carcinoma. The…”
Get full text

5PSQ-030 Safety and security of ciclosporin eye drops in patients with xerophthalmia by Herrera Expósito, M, Bretones Pedrinaci, JI, Urda Romacho, J, Castro Vida, MA

“…Background and ImportanceCiclosporin 1 mg/ml eye drops is indicated for the use of xerophthalmia in patients with severe keratitis unresponsive to artificial…”
Get full text

4CPS-258 Evaluation of medicines adherence and associated factors in patients with chronic hepatitis B by Urda-Romacho, J, Canto-Mangana, J, Castro Vida, MA, Pinto-Nieto, CM

“…Background and importanceChronic hepatitis B virus (HBV) infection is a major public health problem worldwide. Patients‘ knowledge about their disease and/or…”
Get full text

5PSQ-067 Are poly (ADP-ribose) polymerase inhibitors well tolerated by our patients? A safety study in real-word practice by Rubio Calvo, D, Tejedor Tejada, E, Martinez Velasco, E, Urda, J, Castro Vida, MA

“…Background and importancePoly (ADP-ribose) polymerase inhibitors (PARPi) are used for maintenance therapy in ovarian cancer after a platinum-sensitive relapse…”
Get full text

5PSQ-068 Incidence of post-artesunate-induced hamolysis after severe malaria by Bretones Pedrinaci, JI, Rubio Calvo, D, Herrera Exposito, M, Urda, J, Castro Vida, MA

“…Background and importanceIntravenous artesunate is the main therapy for severe malaria. Overall it is a well-tolerated treatment but, in some cases, could lead…”
Get full text

4CPS-264 Analysis of medical treatment, risk factors and recurrence of Clostridioides difficile nosocomial diarrhoea by Bretones Pedrinaci, JI, Martos Rosa, A, Herrera Exposito, M, Urda Romacho, J, Castro Vida, MA

“…Background and importanceThe frequency of Clostridioides difficile infection (CDI) has been increasing worldwide to become one of the most common…”
Get full text

4CPS-345 Management of bronchiolitis in hospitalised children by Aznar Garcia, M, Avila Cabrera, F, Rubio Calvo, D, Castro Vida, MA, Martos Rosa, A, Herrera Exposito, M

“…Background and importanceBronchiolitis is a common cause of hospitalisation in infants. Clinical guideline recommendations are based on supportive treatment…”
Get full text

4CPS-259 One year with bictegravir/emtricitabine/tenofovir alafenamide by Gutiérrez Lorenzo, M, Urda Romacho, J, Rubio Calvo, D, Castro Vida, MA, Pinto Nieto, CM

“…Background and importanceBictegravir (BIC), a second generation integrase strand transfer inhibitor, approved for HIV treatment in fixed dose combination with…”
Get full text

4CPS-376 Antiretroviral therapy optimisation strategies in patients infected with human immunodeficiency virus: a decisive task for hospital pharmacists by Rubio Calvo, D, Gutierrez Lorenzo, M, Urda Romacho, J, Pinto Nieto, CM, Castro Vida, MA

“…Background and importanceAntiretroviral therapy (ART) for human immunodeficiency virus (HIV) cause a significant economic impact on health systems worldwide…”
Get full text

5PSQ-122 Health results after infliximab pharmacokinetic monitoring in inflammatory bowel disease by Herrera Expósito, M, Martinez De La Plata, JE, Rubio Calvo, D, Pinto Nieto, CM, Canto Mangana, J, Castro Vida, MA

“…Background and importanceInfliximab (IFX) is a monoclonal antibody (inhibitor of alpha tumour necrosis factor (anti-TNFα)) which is used in the management of…”
Get full text

4CPS-330 Individualising therapies through pharmacokinetics: adalimumab for inflammatory bowel disease by Rubio Calvo, D, Herrera Exposito, M, Martinez De La Plata, JE, Pinto Nieto, CM, Castro Vida, MA

“…Background and importanceBiologic drugs are essential in the treatment of inflammatory bowel diseases (IBD) but it is necessary to individualise these…”
Get full text

4CPS-245 Duration of antibiotic treatment in patients discharged from a short stay hospitalisation unit by Pinto-Nieto, C, Conde Baena, P, Canto Mangana, J, Martos Rosa, A, Casado Robles, B, Garre Gonzalvez, MA, Alvarez Corral, G, Herrera Exposito, M, Martinez De La Plata, JE, Castro Vida, MA

“…Background and importanceShortening the duration of antibiotic treatment is one of the cornerstones to reduce antibiotic pressure and, therefore, the…”
Get full text

4CPS-055 Efficacy and safety of artemisinine derivatives in the treatment of malaria by Gonzalez Vaquero, D, Castro Vida, MA, Urda Romacho, J, Martos Rosa, A, Avila Cabrera, F, Aznar García, M, Acosta Robles, P

“…BackgroundMalaria is a parasitic disease caused by the parasite Plasmodium falciparum that is transmitted through the bite of infected Anopheles female…”
Get full text

5PSQ-128 Thromboprophylaxis in the emergency department. adequacy of the prescription by Jofré, A, Bretones, JI, Herrera Expósito, M, Urda Romacho, J, Castro Vida, MÁ, Canto-Mangana, J

“…Background and ImportanceIn Europe, the VITAE study estimates an annual incidence of venous thromboembolic disease (VTD) of 243/100,000 inhabitants.About 25%…”
Get full text

6ER-024 What our patients know about antibiotics and antimicrobial resistance. Are they aware of how to make good use of them? by Herrera Expósito, M, Martos-Rosa, A, Aznar-García, M, Pinto Nieto, CM, Castro-Vida, MA

“…Background and importanceAntimicrobial resistance is the ability of microorganisms to evade the effect of antibiotics. The use and abuse of these drugs has…”
Get full text

PKP-002 Security profile of patients treated with phenytoin in a hospital by Morales-Molina, JA, Romacho, J Urda, Martín, JM Fernández, Vaquero, D González, Vida, MA Castro, Robles, P Acosta

“…BackgroundDetermination of the plasma concentration of free phenytoin (CpFL) could improve seizure control and prevent adverse effects.PurposeTo evaluate the…”
Get full text

4CPS-351 Medication delivery confirmation to ambulatory patients by instant messaging app by Gutiérrez Lorenzo, M, Vida, MÁ Castro, Urda Romacho, J, Pinto Nieto, C

“…Background and importanceFaced with the lockdown caused by COVID-19 since March 2020, we have been reorganising the external patient department to get…”
Get full text